Phathom Pharmaceuticals, Inc. PHAT Total Liabilities
Total Liabilities at other companies
Other financials
Where this comes from
Reported directly by Phathom Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:Liabilities.
The official record: Phathom Pharmaceuticals, Inc.’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Phathom Pharmaceuticals, Inc.'s total liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Phathom Pharmaceuticals, Inc.'s total liabilities?
- Phathom Pharmaceuticals, Inc. (PHAT) reported total liabilities of $642.08M in Q1 2026.
- How has Phathom Pharmaceuticals, Inc.'s total liabilities changed year-over-year?
- Phathom Pharmaceuticals, Inc.'s total liabilities increased by 1.5% year-over-year, from $632.58M to $642.08M.
- What is the long-term trend for Phathom Pharmaceuticals, Inc.'s total liabilities?
- Over 5 years (2020 to 2025), Phathom Pharmaceuticals, Inc.'s total liabilities has grown at a 47.2% compound annual growth rate (CAGR), from $100.84M to $697.32M.
- What does total liabilities mean?
- The sum of all current and non-current obligations — everything the company owes to creditors, employees, governments, and other stakeholders.